Unique PABP2 mutations in "Cajuns" suggest multiple founders of oculopharyngeal muscular dystrophy in populations with French ancestry.

Oculopharyngeal muscular dystrophy (OPMD) is an adult-onset autosomal dominant myopathy found world-wide, but with the highest incidence in French-Canadians. Short GCG expansions in the poly(A) binding protein 2 (PABP2) gene were identified recently as the molecular basis for OPMD in French-Canadians. All French-Canadian cases of OPMD have been traced to a single founder couple [Bouchard, 1997: Neuromuscul Disord 7(Suppl):S5-S11]. Cultural links between French-Canadians and Cajuns suggest that this same founder couple may have transmitted the OPMD mutation to Cajuns as well. To determine if OPMD patients from Louisiana share a founder effect with French-Canadian families, we collected blood samples and muscle biopsies from several Cajuns with OPMD for mutation and linkage studies. We found a unique 'GCA GCG GCG' insertion mutation in Cajuns. Consistent with these sequence data, we identified a disease haplotype in our Cajun families that is different from the ancestral haplotype defined in French-Canadians. These data prove that different founders introduced the PABP2 mutation to Cajuns and French-Canadians and lend support to emerging genealogical data suggesting that French-Canadians and Cajuns represent distinct immigrant groups from France.

[1]  J. Bouchard,et al.  Oculopharyngeal Muscular Dystrophy , 1999, Seminars in neurology.

[2]  M. Giuliani,et al.  Oculopharyngeal muscular dystrophy: Non–French‐Canadian pedigrees , 1998, Muscle & nerve.

[3]  R. Cantor,et al.  Genetic mapping and haplotype analysis of oculopharyngeal muscular dystrophy , 1998, Neuroreport.

[4]  J. Rommens,et al.  Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy , 1998, Nature Genetics.

[5]  J. Bouchard,et al.  Using the full power of linkage analysis in 11 French Canadian families to fine map the oculopharyngeal muscular dystrophy gene , 1997, Neuromuscular Disorders.

[6]  J. Bouchard.  André Barbeau and the oculopharyngeal muscular dystrophy in French Canada and North America , 1997, Neuromuscular Disorders.

[7]  M. Pericak-Vance,et al.  Confirmation of linkage of oculopharyngeal muscular dystrophy to chromosome 14q11.2-q13 in American families suggests the existence of a second causal mutation , 1997, Neuromuscular Disorders.

[8]  H. Reichmann,et al.  Oculopharyngeal muscular dystrophy in a northern German family linked to chromosome 14q, and presenting carnitine deficiency , 1997, Neuromuscular Disorders.

[9]  Cécile Fizames,et al.  A comprehensive genetic map of the human genome based on 5,264 microsatellites , 1996, Nature.

[10]  J. Weissenbach,et al.  The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac α and β myosin heavy chain genes on chromosome 14q11.2−q13 , 1995 .

[11]  J. Bouchard,et al.  [Genealogical study of oculopharyngeal dystrophy at Saguenay-Lac-St-Jean, Quebec, Canada]. , 1992, Revue neurologique (Paris).

[12]  A. Barbeau,et al.  Recessive ataxia in Acadians and “Cajuns” , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[13]  K. Krause,et al.  An autopsy study of a familial oculopharyngeal muscular dystrophy (OPMD) with distal spread and neurogenic involvement , 1981, Muscle & nerve.

[14]  A. Barbeau.  The Syndrome of Hereditary Late Onset Ptosis and Dysphagia in French Canada , 1966 .